en / es /
Consulta nuestras publicaciones

Recursos

Descubre la contribución de OWL Metabolomics al conocimiento científico en nuestra sección de Recursos. Te invitamos a consultar las publicaciones en las que hemos participado, que ofrecen perspectivas clave sobre diferentes áreas terapéuticas. Nuestra biblioteca está aquí para ayudarle en tus necesidades de investigación. Te invitamos a explorar nuestras contribuciones con los recursos que ponemos a tu disposición. Utiliza los filtros para encontrar información por año de publicación, área terapéutica y/o enfermedad.
Área
Aging Basic science Cardiology Cardiovascular Dermatology Ecology Endocrinology Fertility Gynecology Andrology Gastroenterology Hepatology Endocrinology Inmunology Metabolomics Neuroscience Nutrition Oncology Ophtalmology
Patología
Acute myeloid leukemia Aging Alcoholic Hepatitis Alzheimer’s Disease amyotrophic lateral sclerosis Andrology Atopic dermatitis Bile acid diarrhoea Cardiovascular disease Cholangiocarcinoma Primary sclerosing cholangitis Chronic venous disease Cirrhosis Colorectal cancer Cushing syndrome Diabetes Diet in gestation DILI Ecology Fertility Fuchs endothelial dystrophy Glaucoma Hepatitis C Hepatoblastoma Hepatocellular carcinoma HIV Hypercholesterolemia Inflammation Lipodistrophy Liver fibrosis Membrane biophysics Metabolomics Multiple sclerosis NAFLD/NASH T2DM Nutrition Obesity Ovarian endometriosis Pancreatic cancer Pancreatic ductal adenocarcinoma Parkinson’s Disease Pharmacometabolomics Prostate cancer Schwann cell myelination Toxicity Vaccinia Virus Infection Vascular disease Wilson’s disease
Año
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2008
Metabolomics as a tool to predict the risk of decompensation or liver related death in patients with compensated cirrhosis.
Hepatology 2023;77(6):2052-62. / 2023
Área: Gastroenterology / Hepatology
Patología: Cirrhosis
Impaired Function of Solute Carrier Family 19 Leads to Low Folate Levels and Lipid Droplet Accumulation in Hepatocytes.
Biomedicines 2023;11(2):337. / 2023
Área: Gastroenterology / Hepatology
Patología: NAFLD/NASH
A Novel Approach on the Use of Samples from Faecal Occult lood Screening Kits for Metabolomics Analysis: Application in Colorectal Cancer Population.
Metabolites 2023;13(3):321 / 2023
Área: Oncology
Patología: Colorectal cancer
Serum lipidome unravels a diagnostic potential in bile acid diarrhoea.
Gut (in press) / 2023
Área: Gastroenterology / Hepatology
Patología: Bile acid diarrhoea
Spatial Metabolomics and its Application in the Liver.
Hepatology (in press) / 2023
Área: Metabolomics
Patología: Metabolomics
Classification of common food lipid sources regarding healthiness using advanced lipidomics: a four-arm crossover study.
Int J Mol Sci. 2023;24(5):494. / 2023
Área: Nutrition
Patología: Nutrition
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma.
J Hepatol. (in press) / 2023
Área: Oncology
Patología: Hepatoblastoma
Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy
Cancers 2023;15(12):3145 / 2023
Área: Oncology
Patología: Acute myeloid leukemia
A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures.
Nat Metab. 2023; 5:572-578. / 2023
Área: Gastroenterology / Hepatology
Patología: NAFLD/NASH
Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study.
Lancet Gastroenterol Hepatol. (in press) / 2023
Área: Gastroenterology / Hepatology
Patología: NAFLD/NASH
Dietary and genetic disruption of hepatic methionine metabolism induce acid sphingomyelinase to promote steatohepatitis.
Redox Biol. 2023;59:102596. / 2023
Área: Gastroenterology / Hepatology
Patología: NAFLD/NASH
The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats.
Biomed Pharmacother. 2023;161:114535. / 2023
Área: Gastroenterology / Hepatology & Endocrinology
Patología: NAFLD/NASH and T2DM
1 2 … 13
Cookies
We use our own and third-party cookies to be able to correctly offer you all the functionalities of the website, for analytical purposes and to show you personalized advertising according to a profile prepared from your browsing habits. You can accept all cookies by clicking "Accept cookies", obtain more information in our" Cookie policy or configure them or reject their use by clicking on Configuration.".
Accept Cookies Configure
Basic cookie information
This website uses cookies and/or similar technologies that store and retrieve information when you browse. In general, these technologies can serve very different purposes, such as, for example, recognizing you as a user, obtaining information about your browsing habits or customizing the way in which the content is displayed. The specific uses we make of these technologies are described below. By default, all cookies are disabled, except for the technical ones, which are necessary for the website to work. If you wish to expand the information or exercise your data protection rights, you can consult our Cookies Policy.".
Accept cookies Manage preferences
Technical and/or necessary cookies Always active
Technical cookies are those that facilitate user navigation and the use of the different options or services offered by the web such as identifying the session, allowing access to certain areas, facilitating orders, purchases, filling in forms, registration, security, facilitating functionalities. (videos, social networks…).
Analysis cookies
Analysis cookies are those used to carry out anonymous analysis of the behavior of web users and that allow user activity to be measured and navigation profiles to be created with the objective of improving websites.
Analysis cookies
Analysis cookies are those used to carry out anonymous analysis of the behavior of web users and that allow user activity to be measured and navigation profiles to be created with the objective of improving websites.
Confirm preferences
Lo último

Noticias
y actualidad

Prensa 02/08/2023 OWL Metabolomics colabora en la publicación del MASEF Score para identificar a pacientes en riesgo de MASH Saber más
Evento 20/06/2023 OWL Metabolomics asiste al Congreso EASL 2023 Saber más
Noticia 14/06/2023 OWL Metabolomics se une a Laboratorios Rubió en un apasionante avance en el campo de la metabolómica Saber más
Linkedin Twitter
By Rubió
Carrer Indústria 29, Polígon Industrial Comte de Sert 08755
Castellbisbal, Barcelona (España), +34 937 722 509 – labrubio@labrubio.com
Popupcontent
Accept